ASX:HLS (Australia)  
Healius Ltd logo

Healius Ltd

A$ 3.46 (-0.29%) Oct 6
P/E:
6.66
P/B:
1.02
Market Cap:
A$ 2.02B ($ 1.32B)
Enterprise V:
A$ 3.71B ($ 2.43B)
Volume:
1.53M
Avg Vol (2M):
2.70M
Also Trade In:
Volume:
1.53M
Market Cap A$:
2.02B
Market Cap $:
1.32B
PE Ratio:
6.66
Avg Vol (2-Month):
2.70M
Enterprise Value A$:
3.71B
Enterprise Value $:
2.43B
PB Ratio:
1.02
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 70% of revenue from pathology, 25% from diagnostic imaging and a small remainder from day hospitals.

Financials (Next Earnings Date:2023-02-08 Est.)

ASX:HLS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 2,336.2
EPS (TTM) (A$) 0.52
Beta 1.35
Volatility % 26.76
14-Day RSI 46.31
14-Day ATR (A$) 0.101941
20-Day SMA (A$) 3.472
12-1 Month Momentum % -22.06
52-Week Range (A$) 3.26 - 5.54
Shares Outstanding (Mil) 580.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Healius Ltd Filings

Document Form Filing Date
No Filing Data

Healius Ltd Analysis

Share your research